Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain

Ravindranadh V. Somu, Daniel J. Wilson, Eric M. Bennett, Helena I. Boshoff, Laura Celia, Brian J. Beck, Clifton E. Barry, Courtney C. Aldrich

Research output: Contribution to journalArticlepeer-review

71 Scopus citations


Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen. We previously demonstrated that a bisubstrate inhibitor of the adenylation enzyme MbtA, which is responsible for the second step of mycobactin biosynthesis, exhibited potent antitubercular activity. Here we systematically investigate the structure-activity relationships of the bisubstrate inhibitor glycosyl domain resulting in the identification of a carbocyclic analogue that possesses a KIapp value of 2.3 nM and MIC99 values of 1.56 μM against M. tuberculosis H37Rv. The SAR data suggest the intriguing possibility that the bisubstrate inhibitors utilize a transporter for entry across the mycobacterial cell envelope. Additionally, we report improved conditions for the expression of MbtA and biochemical analysis, demonstrating that MbtA follows a random sequential enzyme mechanism for the adenylation half-reaction.

Original languageEnglish (US)
Pages (from-to)7623-7635
Number of pages13
JournalJournal of medicinal chemistry
Issue number26
StatePublished - Dec 28 2006


Dive into the research topics of 'Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain'. Together they form a unique fingerprint.

Cite this